Cambrian Bioworks develops integrated molecular-diagnostics solutions spanning nucleic acid extraction kits, workflow automation, and NGS library-preparation automation. Our portfolio is designed to help research and clinical laboratories improve throughput, consistency, turnaround time, and ease of implementation across DNA/RNA extraction and downstream molecular workflows.
Our extraction-kit portfolio supports demanding sample types and applications, including high-yield cfDNA extraction from plasma for NIPT and liquid-biopsy workflows; DNA/RNA extraction for molecular diagnostics; FFPE biopsy processing for cancer genomics; high-molecular-weight DNA extraction from stool for long-read sequencing; and magnetic-bead clean-up, DNA size selection, and PCR clean-up for NGS library preparation.
Our automation platforms extend these workflows end-to-end:
Manta: Automated DNA/RNA extraction for clinical and research applications.
Beluga: A fully automated sample-to-result platform integrating nucleic acid extraction, quantification, and amplification.
Orca: A modular automation platform for complex next-generation sequencing library-preparation workflows.
We work with diagnostic laboratories, genomics service providers, researchers, and technology partners to deploy scalable, reliable workflows—from small research teams to high-throughput facilities. We also collaborate on workflow optimization, application development, and co-development opportunities tailored to specific sample types, assays, and laboratory requirements.
Cambrian Bioworks is a biotechnology research company founded in 2020 that develops automated solutions for genomic testing and molecular diagnostics. The company designs and manufactures specialized hardware and software to streamline workflows such as DNA and RNA extraction and library preparation. By integrating bead-based systems with automation, their technology is engineered to be flexible, intuitive, and accessible to clinical laboratories. A core product, the Manta platform, is CE-marked under IVDR and holds CDSCO certification, reflecting the company’s commitment to meeting rigorous clinical quality and reliability standards in its diagnostic tools.
These solutions are designed to support precision medicine, oncology, infectious disease diagnostics, and genetic testing, ultimately aiming to democratize lab technology and assist scientists in providing fast, accurate results for patient care. Headquartered in Bangalore, India, with a presence in the United States, Cambrian Bioworks functions as a team of engineers, scientists, and chemists focused on building products that address the high-stakes needs of molecular diagnostic workflows. Through these efforts, they work to improve diagnostic efficiency and accessibility, enabling laboratories to maintain greater control over their testing processes and data.